Unsolved issues in CLL biology and management.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.Blood · 2011
   Trial
2. Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia.Biology · 2022
   Article
3. Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2019
   Article
4. Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.Molecules (Basel, Switzerland) · 2017
   Review
5. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.Chinese medical journal · 2017
   Article
6. Myelodysplastic Syndrome and Acute Lymphocytic Leukemia in Common Variable Immunodeficiency (CVID).Journal of clinical immunology · 2016
   Article
7. To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients.Oncotarget · 2016
   Article
8. Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.Current opinion in oncology · 2012
   Review
9. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.PloS one · 2012
   Article
10. Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.Leukemia & lymphoma · 2011
    Article
11. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.Leukemia · 2010
    Article
12. A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.Haematologica · 2009
    Article
13. Evidence for involvement of clonally expanded CD8+ T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation.Leukemia · 2005
    Article
14. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.Leukemia · 2005
    Article
15. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.Leukemia · 2004
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as